Quick Dispatch:
Your iih and glp 1 Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your iih and glp 1 Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals ships.
Need Help?
Questions about iih and glp 1 Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for iih and glp 1 Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals in your area.
NeuroOp Guru: Stopping GLP-1 therapy may trigger recurrent papilledema in IIH cases | Ophthalmology Times
24.99
Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study
20.47
IIH (Idiopathic Intracranial Hypertension): Symptoms, Diagnosis & Treatment
26.50
Association between GLP-1 receptor agonist use and neurosurgical intervention in patients with idiopathic intracranial hypertension and obesity: a propensity-matched, multi-institutional, cohort study
26.20
Proposed pathophysiological mechanisms underlying IIH and the target
20.04
Recurrent Idiopathic Intracranial Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema
25.63
Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain
25.84
